"We have patients who we’ve been following for over twenty years. We’re going to grow old together."
Where I see patients (3)
My work
Q&A: Walking patients back from the precipice
UCSF is known for excellent lung transplant outcomes, despite accepting the most challenging cases. Dr. Hays reveals what's behind the program's success.
My reviews
Selected research
-
CD94+ natural killer cells potentiate pulmonary ischaemia-reperfusion injury.
The European respiratory journal
-
Improvements in Patient-Reported Functioning after Lung Transplant is Associated with Improved Quality of Life and Survival.
medRxiv : the preprint server for health sciences
-
Small airway brush gene expression predicts chronic lung allograft dysfunction and mortality.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
4.9